Navigation Links
Biotherapeutic Innovations on Display at AAPS National Biotechnology Conference
Date:5/11/2010

ARLINGTON, VA (May 11, 2010) Advancement in the treatment of cocaine overdoses and a new defense in the fight against HIV are just two examples of the groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC). The conference takes place Sunday, May 16 -Thursday, May 20 at the Hilton San Francisco Union Square in San Francisco, Calif.

A Possible Treatment for Cocaine Addiction

Researchers from the University of Kentucky have discovered high-activity mutants of human butyrylcholinesterase (BChE) that have potential value in the development of anti-cocaine medication. The ideal treatment accelerates cocaine metabolism by producing biologically inactive metabolites via a route similar to the primary cocaine-metabolizing pathway.

"Cocaine addiction and overdose are well-known public health problems; there is no FDA (Food and Drug Administration)-approved medication specifically for cocaine abuse treatment," said Chang-Guo Zhan, Ph.D., research team leader and professor of pharmaceutical sciences at Kentucky. "In this research, we aim to design and discover an efficient cocaine hydrolase, which can be used for therapeutic treatment of cocaine overdose, and we have discovered one by engineering BChE."

The design has been successfully tested in mice. Zhan will present this research during the Sunrise Session on "Computational Approaches to Protein Drug Discovery and Development," from 7 a.m. to 8 a.m. on Tuesday, May 18, and at the Roundtable Session on "Rational Design of Protein Drug Stabilization," from 10:30 a.m. to 12:00 p.m. on Wednesday, May 19.

Developing Countries See Hope in the Battle against HIV

The possibility for a microbiocide-based HIV prevention measure holds particular promise for developing countries, particularly in sub-Saharan Africa, where the number of people living with HIV, as of 2008, was 22.4 million according to a report by the Joint United Nations Programme on HIV/AIDS and the World Health Organization . Microbiocides gives women, particularly in patriarchal societies, a level of confidence and control when it comes to contraception use; this particular microbiocide would be a dissolving film as opposed to microbiocides that require a plastic applicator, which makes for more discreet usage and less waste.

These studies and other novel research will be presented during a week of educational programming devoted to advancing health through biotherapeutics. Conference programming consists of a Plenary Session, symposia, roundtables, posters, hot topics, and concludes with two short courses. Additionally, the Exposition Hall will be hosting over 100 companies.


'/>"/>

Contact: Joseph Catapano
catapanoj@aaps.org
703-248-4772
American Association of Pharmaceutical Scientists
Source:Eurekalert

Related biology news :

1. Leaders from the National Academies gather to discuss engineering innovations in health care
2. MIT student develops new innovations to selectively kill cancer cells
3. New research program for energy innovations
4. Innovations in Pediatric Medicine International Conference brings together pediatrics experts
5. Innovations in Pediatric Medicine CME conference brings together national pediatrics experts
6. Improving industry efficiency through environmental innovations
7. New chemical radar among national security innovations in ACS podcast
8. Sonic Innovations Celebrates 10-Year Anniversary
9. Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree
10. OHSU turns innovations into commercial opportunities at record pace
11. Touch the Earth to display at Earth Day on National Mall
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , ... announced today the Clinical Reach Virtual Patient Encounter CONSULT module which enables ... the physician and clinical trial team. , Using the CONSULT module, patients and physicians ...
(Date:6/27/2016)...   Ginkgo Bioworks , a leading organism ... today awarded as one of the World Economic ... most innovative companies. Ginkgo Bioworks is engineering biology ... world in the nutrition, health and consumer goods ... customers including Fortune 500 companies to design microbes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita ... miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject of ... now. , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology: